NACT

DRUG3 trials

Sponsors

Tata Memorial Hospital, Huazhong University of Science and Technology, Peking University

Conditions

Cancer of CervixCervical CancerGastric CancerUterine Cervical CancerUterine Cervical Neoplasm

Phase 3

Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix

Tata Memorial HospitalCancer of Cervix

Start: 2003-09-04End: 2020-07-31Updated: 2019-09-20

Clinical Efficacy of the Neoadjuvant Chemotherapy for IB2 and IIA2 Stage Cervical Cancer Patients

CompletedNCT03308591

Huazhong University of Science and TechnologyCervical Cancer, Uterine Cervical Cancer, Uterine Cervical Neoplasm

Start: 2016-01-11End: 2022-02-01Updated: 2024-10-31

Unknown Phase

Real World Evidence for the Cycle of Neoadjuvant Chemotherapy in Gastric Cancer With Shared Decision Making

Peking UniversityGastric Cancer

Start: 2018-01-03End: 2023-01-03Target: 100Updated: 2018-01-29

Related Papers

Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial.

2022-12-0514 citations

Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial

Journal of Clinical Oncology2018-02-12451 citations